Hiroyasu Naba

A novel anti-HIV synthetic peptide, T-22 ([Tyr5,12,Lys7]-polyphemusin II)

Masao Masuda, Hideki Nakashima, Toshihiro Ueda et al. · Biochemical and Biophysical Research Communications · 1992 · 130 citations

Medicinal Chemistry, Medicine, Immunology +8

Increased cytotoxicity of soluble Fas ligand by fusing isoleucine zipper motif

Tetsuya Shiraishi, Kenji Suzuyama, Hiroaki Okamoto et al. · Biochemical and Biophysical Research Communications · 2004 · 58 citations

Biochemistry, Natural Sciences, Medicine +8

Eisai Hyperbilirubinemic Rat (EHBR) as an Animal Model Affording High Drug-Exposure in Toxicity Studies on Organic Anions

Hiroyasu Naba, Chitose Kuwayama, Chihaya Kakinuma et al. · Drug Metabolism and Pharmacokinetics · 2004 · 24 citations

Eicosapentaenoic acid attenuates statin-induced ER stress and toxicity in myoblast

Masahiko Ohta, Hiroyuki Kawano, Tatsuto Notsu et al. · Biochemical and Biophysical Research Communications · 2012 · 19 citations

Inflammation, Redox Signaling, Biochemistry +10

Pharmacological characterization of a novel potent, selective, and orally active phosphodiesterase 10A inhibitor, PDM‐042 [(<i>E</i>)‐4‐(2‐(2‐(5,8‐dimethyl‐[1,2,4]triazolo[1,5‐<i>a</i>]pyrazin‐2‐yl)vinyl)‐6‐(pyrrolidin‐1‐yl)pyrimidin‐4‐yl)morpholine] in rats: potential for the treatment of schizophrenia

Keita Arakawa, Shunsuke Maehara, Natsuko Yuge et al. · Pharmacology Research & Perspectives · 2016 · 17 citations · Full text